July 07, 2026

Medical Oddities: When a Brush Beats a Scalpel

This research roundup has brain drama, bleeding control, skin science, and tiny brushes.

Conexiant

June 30, 2026

Top 10 Growing Metro Areas With Active HPSAs

These 10 metropolitan areas reported population gains and active federal shortage area designations identified in census and health care workforce data.

Conexiant

June 24, 2026

Promising early results for a new treatment in head and neck cancer

Victoria Villaflor, MD shared promising early results at ASCO 2026 for a new treatment approach in head and neck cancer.

UCI Health

June 22, 2026

Accuracy of AI Laryngeal Disorder Detection

Review of 88 studies found AI systems achieved high accuracy for identifying abnormal voices, but performance declined among higher-level laryngeal disorder classifications.

Conexiant

June 22, 2026

Deprivation Tied to Lower HNC-Specific QOL

The differences were present before patients began any treatment, suggesting quality-of-life gaps may be established before therapy begins.

Conexiant

June 19, 2026

Most Miss Streamlined Neck Mass Dx Path

Same-visit biopsy and fewer empiric workup steps were linked to faster pathologic diagnosis in a retrospective analysis.

Conexiant

June 15, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

Conexiant

June 05, 2026

Chemoimmunotherapy Linked to HNSCC Response

Higher pathologic response rates with chemoimmunotherapy versus immunotherapy alone call for phase 3 trials, but survival implications remain unknown.

Conexiant

June 05, 2026

Poor Diet Quality Linked to Oral Cancer

Large prospective cohort data showed stronger associations among women without substantial tobacco or alcohol exposure.

Conexiant

June 04, 2026

NHS-Galleri Linked to Delays

Analysis of England’s multicancer early detection screening trial found modest, temporary diagnostic delays in participating regions, adding to concerns about health system effects and the evidence base for population-level blood-based cancer screening.

Conexiant